Cazenove Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Cazenove Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$30.3K	Buy	+382	New	+$30.6K	0.02%	149

Other funds holding MJN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cazenove Capital Management's MJN Position: Q2 2013 in Review

Cazenove Capital Management opened a new position in Mead Johnson Nutrition Company (MJN) in Q2 2013: 382 shares worth $30.3K. The stake represents 0.02% of the portfolio and ranks #149 among its holdings.

458 funds tracked by Wall St. Rank hold MJN as of Q2 2013.

Cazenove Capital Management held 382 shares of Mead Johnson Nutrition Company worth $30.3K as of Q2 2013.
Mead Johnson Nutrition Company was a new Cazenove Capital Management position in Q2 2013.
Mead Johnson Nutrition Company made up 0.02% of Cazenove Capital Management's portfolio in Q2 2013, its #149 holding.
458 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2013.

Based on Cazenove Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.